- Home
- ALTG vs TLSI Comparison
ALTG vs TLSI Comparison
Compare ALTG & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- TLSI
- Stock Information
- Founded
- ALTG 1984
- TLSI 2010
- Country
- ALTG United States
- TLSI United States
- Employees
- ALTG N/A
- TLSI N/A
- Industry
- ALTG Industrial Machinery/Components
- TLSI Medical Specialities
- Sector
- ALTG Industrials
- TLSI Health Care
- Exchange
- ALTG Nasdaq
- TLSI Nasdaq
- Market Cap
- ALTG 206.7M
- TLSI 244.3M
- IPO Year
- ALTG N/A
- TLSI N/A
- Fundamental
- Price
- ALTG $4.81
- TLSI $6.21
- Analyst Decision
- ALTG Hold
- TLSI Strong Buy
- Analyst Count
- ALTG 3
- TLSI 3
- Target Price
- ALTG $11.33
- TLSI $10.67
- AVG Volume (30 Days)
- ALTG 227.8K
- TLSI 114.0K
- Earning Date
- ALTG 11-06-2025
- TLSI 11-13-2025
- Dividend Yield
- ALTG 2.37%
- TLSI N/A
- EPS Growth
- ALTG N/A
- TLSI N/A
- EPS
- ALTG N/A
- TLSI N/A
- Revenue
- ALTG $1,824,900,000.00
- TLSI $40,207,000.00
- Revenue This Year
- ALTG $1.30
- TLSI $57.25
- Revenue Next Year
- ALTG $3.26
- TLSI $54.05
- P/E Ratio
- ALTG N/A
- TLSI N/A
- Revenue Growth
- ALTG N/A
- TLSI 49.52
- 52 Week Low
- ALTG $3.54
- TLSI $3.42
- 52 Week High
- ALTG $8.99
- TLSI $6.36
- Technical
- Relative Strength Index (RSI)
- ALTG 39.70
- TLSI 77.66
- Support Level
- ALTG $4.16
- TLSI $3.79
- Resistance Level
- ALTG $4.59
- TLSI $4.88
- Average True Range (ATR)
- ALTG 0.34
- TLSI 0.47
- MACD
- ALTG 0.01
- TLSI 0.17
- Stochastic Oscillator
- ALTG 34.48
- TLSI 96.84
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.